
Pharmaceuticals & Healthcare · NSE
Incorporated in 2015, Sotac Pharmaceuticals Limited, part of the Gujarat-based SOTAC Group, is engaged in manufacturing pharmaceutical products for various marketers on a loan license and contract manufacturing basis. Serving over 162 corporate clients, the company operates primarily on a principal-to-principal model. Established in 2017, its manufacturing facility has an annual capacity of 90 crore tablets and 14 crore capsules. Backed by promoters with over 59 years of combined industry experience, Sotac Pharmaceuticals continues to expand and strengthen its presence in the pharmaceutical sector.
Price Band
₹105 – ₹111
Issue Size
₹33.30 Cr
Lot Size
1200 shares
GMP
Est. Listing
₹111
at current GMP
Subscribed
1.60x
overall
Open
29 Mar 2023
Close
3 Apr 2023
Allotment
10 Apr 2023
Refund
11 Apr 2023
Demat Credit
12 Apr 2023
Listing
13 Apr 2023
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹111
Band: ₹105 – ₹111
Estimated Listing Price
₹111
Upper price + GMP
Lot Size
1200 shares
Min investment ₹1,33,200
Estimated Profit / Lot
₹0
1200 × ₹0
Grey Market Premium trend
—
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹111 |
| 30 Oct 2026 | — | 0.0% | ₹111 |
| 29 Oct 2026 | — | 0.0% | ₹111 |
GMP is unofficial market data. Not a guarantee of listing performance.
Sotac Pharmaceuticals Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹33.3 Crores. The shares are offered at a price band of ₹105 to ₹111 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1200 shares (approx. ₹1,33,200 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-04-12, while un-allotted funds or UPI block mandates will be released on 2023-04-11.
The latest grey market premium for Sotac Pharmaceuticals Limited IPO is ₹0, which indicates an expected listing price of ₹111.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.